BAP-65 Score for Acute COPD Exacerbation: Clinical Guide

Overview

Risk-stratifies adults admitted with acute exacerbation of COPD using blood urea nitrogen, mental status, pulse and age.

Clinical Significance

Higher classes are associated with increasing need for mechanical ventilation and in-hospital mortality. The score supports early risk stratification but does not dictate treatment.

When to Use

• Use when the patient and clinical question match the population and purpose described.
• Use accurate current inputs and preserve the original score definitions.

How It Is Calculated

• One point is assigned for each of: BUN ≥25 mg/dL (8.9 mmol/L), altered mental status, pulse ≥109/min and age ≥65 years. Total 0–4, corresponding to ascending BAP-65 classes.

Interpretation

• Higher classes are associated with increasing need for mechanical ventilation and in-hospital mortality. The score supports early risk stratification but does not dictate treatment.

Worked Example

Enter a complete, clinically consistent set of values. MedicalC then applies the published method: One point is assigned for each of: BUN ≥25 mg/dL (8.9 mmol/L), altered mental status, pulse ≥109/min and age ≥65 years. Total 0–4, corresponding to ascending BAP-65 classes.

Patient Considerations

• Validated in hospitalised adults with acute COPD exacerbation. It should not be extrapolated uncritically to asthma, bronchiectasis, pneumonia without COPD or patients aged 40 years or younger.

Limitations

• Tachycardia, urea elevation and altered mental status may reflect alternative or additional diagnoses such as sepsis, pulmonary embolism, arrhythmia, dehydration or medication effects.
• Performance and calibration may differ outside the derivation and validation settings.
• The result supports but does not replace clinical assessment, investigation or local guidance.

Clinical Pearls

• A low BAP-65 score should never override severe acidosis, exhaustion, refractory hypoxaemia or other immediate indications for escalation.
• Document component values as well as the final result.

Common Mistakes

• Using an incorrect threshold, unit or category definition.
• Applying the tool to a population for which it has not been validated.
• Treating the calculated category as a diagnosis or automatic treatment instruction.

Evidence Base

Tabak YP et al. Development and validation of a mortality risk-adjustment model for patients hospitalized for exacerbations of chronic obstructive pulmonary disease. Med Care. 2013.

References

1. Tabak YP et al. Development and validation of a mortality risk-adjustment model for patients hospitalized for exacerbations of chronic obstructive pulmonary disease. Med Care. 2013. — Primary or authoritative source supporting the implemented method.